Topic Collection Search
Allergy and immunology
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Geriatric medicine / aging
Haematology / blood transfusion
History of medicine
Legal and forensic medicine
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Organisation of health care
Otolaryngology / head and neck surgery
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Quality of care
Statistics and research methods
This article analyses the current legal framework in Switzerland and critically evaluates existing reimbursement models, particularly with respect to their adaptation for advanced therapy medicinal products. As a promising reimbursement arrangement, this paper proposes a model combining outcome-based instalment payments with aspects of the pay for performance and the annuity payment model.
The economic and public health impact of influenza vaccinations: contributions of Swiss pharmacies in the 2016/17 and 2017/18 influenza seasons and implications for vaccination policy
The economic and public health impact of prescriptionless vaccination against influenza in healthy adults in Switzerland has not been studied yet.
Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland
Increasing the number of patients treated and treating all fibrosis stages is cost-effective compared against the historical base case and could achieve a break-even by 2031 at a price of 27,900 CHF.
Hyponatraemia is the most common electrolyte disorder encountered in hospitalised patients and has an impact on outcome and survival. However, the risk factors are not yet sufficiently known.
High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.
Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department
Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.
For the first time in Switzerland, the Swiss hospital registry was used to examine the incidence of ovarian cancer as well as its treatment episodes and costs.
Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight
There is a relatively broad international literature on the cost effectiveness of bariatric surgery, but no systematic reviews that examine the transferability of international cost-effectiveness results for Switzerland or another single country.
In Switzerland, it is now mandatory for medical staff to act according to patients’ advance directives. Unfortunately, even though many people know about their existence, only a small minority actually draft them.
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
Sacubitril/valsartan, an angiotensin-receptor-neprilysin-inhibitor, is a novel oral therapy proposed in the current guidelines for the treatment of heart failure in patients with reduced left ventricular ejection fraction.